Study on the mechanism of Baihe Dihuang decoction in treating menopausal syndrome based on network pharmacology

被引:3
|
作者
Tian, Mingmin [1 ]
Yang, Anming [2 ]
Lu, Qinwei [3 ]
Zhang, Xin [2 ]
Liu, Guangjie [2 ]
Liu, Gaofeng [4 ,5 ]
机构
[1] Jiangxi Univ Tradit Chinese Med, Sch Chinese Med, Nanchang, Peoples R China
[2] Southern Med Univ, Nanfang Hosp, Dept Neurosurg, Guangzhou, Peoples R China
[3] Nanjing Univ Chinese Med, Sch Integrated Chinese & Western Med, P, Nanjing, Peoples R China
[4] Southern Med Univ, Sch Tradit Chinese Med, Guangzhou, Peoples R China
[5] Southern Med Univ, Sch Tradit Chinese Med, Guangzhou 510515, Peoples R China
关键词
analysis of enrichment; Baihe Dihuang decoction; mechanism of action; menopausal syndrome; network pharmacology; targets; RESEARCH PROGRESS;
D O I
10.1097/MD.0000000000033189
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Menopausal syndrome (MS) refers to a series of symptoms with autonomic nervous system dysfunction caused by decreased sex hormones before and after menopause. Baihe Dihuang (BHDH) decoction positively affects MS, but its mechanism remains unclear. This study aimed to reveal the underlying mechanism through network pharmacology. The components of the BHDH Decoction were found through HERB, while corresponding targets were obtained from the HERB, Drug Bank, NPASS, Targetnet, and Swisstarget databases. The MS targets were obtained from GeneCards and OMIM. STRING was used to construct the protein-protein interaction networks. OmicShare tools were used for Gene Ontology and Kyoto encyclopedia of genes and genomes analyses. Finally, Autodock Vina 1.1.2 software () was used for molecular alignment to verify whether the main active ingredients and key targets had good binding activity. We screened out 27 active ingredients and 251 effective targets of BHDH Decoction, 3405 MS-related targets, and 133 intersection targets between BHDH Decoction and MS. Protein-protein interaction network identified tumor protein P53, Serine/threonine-protein kinase AKT, epidermal growth factor receptor, Estrogen Receptor 1, and jun proto-oncogene as critical targets. Gene ontology analysis showed that these targets were mainly involved in the cellular response to chemical stimulus, response to oxygen-containing compound, cellular response to endogenous stimulus, response to an organic substance, and response to chemical, etc. Kyoto encyclopedia of genes and genomes pathways were mainly enriched in endocrine resistance, pathways in cancer, and the ErbB signaling pathway, etc. Molecular docking results showed that emodin and stigmasterol are strongly associated with Serine/threonine-protein kinase AKT, Estrogen Receptor 1, epidermal growth factor receptor, sarcoma gene, and tumor protein P53. This study preliminarily revealed the multi-component, multi-target, and multi-channel mechanism of BHDH Decoction in treating MS. It provides a reference for in vitro and in vivo research and clinical application of BHDH Decoction in the treatment of MS.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Study on mechanism of Zhenwu Decoction in treatment of heart failure based on network pharmacology: A review
    Yan, Sai
    Shi, Qingchun
    Ma, Hongtao
    Xu, Qian
    MEDICINE, 2023, 102 (46) : E36073
  • [32] Investigation of the Underlying Mechanism of Zhibai Dihuang Pill in Treating Osteoporosis by using Network Pharmacology and Molecular Dynamics Simulation
    Feng, Yangyang
    Zhang, Liangliang
    Zhao, Chengjin
    Li, Nannan
    Chang, Baosheng
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2023, 23 (09) : 1201 - 1214
  • [33] Study on the molecular mechanisms of Liuwei Dihuang decoction against aging-related cognitive impairment based on network pharmacology and experimental verification
    Ouyang, Yin
    Chen, Bowei
    Yi, Jian
    Zhou, Siqian
    Liu, Yingfei
    Tian, Fengming
    Zeng, Fanzuo
    Xiao, Lan
    Liu, Baiyan
    HELIYON, 2024, 10 (11)
  • [34] Study on the action mechanism of Wuling Powder on treating osteoporosis based on network pharmacology
    Zhou Hao-Nan
    Li Hao-Yu
    Xu Wen-Hua
    Wei Yan-Yi
    Yu Rui-Xin
    Wang Wei
    Chen Yuan-Ming
    CHINESE JOURNAL OF NATURAL MEDICINES, 2021, 19 (01) : 28 - 35
  • [35] Study on the mechanism of Gualou Xiebai Guizhi decoction (GLXBGZD) in the treatment of coronary heart disease based on network pharmacology
    Teng, Chao
    Wang, Yong
    Pang, Songhai
    Wei, Xiaotong
    Liu, Xiangzhen
    MEDICINE, 2022, 101 (29) : E29490
  • [36] Study on the mechanism of Gegen Qinlian Decoction for treating type II diabetes mellitus by integrating network pharmacology and pharmacological evaluation
    Xu, Xinyi
    Niu, Lulu
    Liu, Yan
    Pang, Meilu
    Lu, Wanying
    Xia, Cong
    Zhu, Yuxuan
    Yang, Bingyou
    Wang, Qi
    JOURNAL OF ETHNOPHARMACOLOGY, 2020, 262
  • [37] Network pharmacology and molecular docking-based analyses to predict the potential mechanism of Huangqin decoction in treating colorectal cancer
    Li, Ying-Jie
    Tang, Dong-Xin
    Yan, Hong-Ting
    Yang, Bing
    Yang, Zhu
    Long, Feng-Xi
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (19) : 4553 - 4566
  • [38] The mechanism of Taohong Siwu decoction in treating chemotherapy-induced peripheral neuropathy: a network pharmacology and molecular docking study
    Zhou, Meiyu
    Liu, Li
    Tan, Yonghong
    Huang, Rui
    Yang, Zailiang
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (07) : 3842 - 3853
  • [39] Investigating the Mechanism of Banxia Xiexin Decoction in Treating Gastritis and Diabetes Mellitus through Network Pharmacology and Molecular Docking Analysis
    Du, Yikuan
    Chi, Xianhong
    Chen, Qianwen
    Xiao, Yue
    Ma, Zhendong
    Wang, Zhenjie
    Guo, Zhuoming
    Chen, Peng
    Chen, Zilin
    Zhang, Mengting
    Guo, Jinyan
    Zhou, Yuqi
    Yang, Chun
    CURRENT DRUG THERAPY, 2024, 19 (07) : 878 - 897
  • [40] Study on the mechanism of Shujin Tongluo granules in treating cervical spondylosis based on network pharmacology and molecular docking
    Wang, Yixuan
    Tao, Xiaoyu
    Gao, Yifei
    Jin, Zhengsen
    Guo, Siyu
    Li, Zhenjiang
    Wang, Mengmeng
    Zhao, Ruoqi
    Zhou, Wei
    Wu, Jiarui
    MEDICINE, 2023, 102 (29) : E34030